Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.21.84 - limulus clotting factor C

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Alveolar Bone Loss
Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss.
Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation.
Arthritis
Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice.
Arthritis, Psoriatic
[Psoriasis arthropathica and seronegative rheumatoid arthritis--differential diagnostic considerations]
Arthritis, Rheumatoid
Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Inflammation and Lymphatic Function.
VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis.
[Psoriasis arthropathica and seronegative rheumatoid arthritis--differential diagnostic considerations]
Azoospermia
A common 1.6 mb Y-chromosomal inversion predisposes to subsequent deletions and severe spermatogenic failure in humans.
A family of human Y chromosomes has dispersed throughout northern Eurasia despite a 1.8-Mb deletion in the azoospermia factor c region.
A frequent Y chromosome b2/b3 subdeletion shows strong association with male infertility in Han-Chinese population.
A novel partial deletion of the Y chromosome azoospermia factor c region is caused by non-homologous recombination between palindromes and may be associated with increased sperm counts.
Additional genomic duplications in AZFc underlie the b2/b3 deletion-associated risk of spermatogenic impairment in Han Chinese population.
An infertile patient with Y chromosome b1/b3 deletion presenting with congenital bilateral absence of the vas deferens with normal spermatogenesis.
Analysis of partial azoospermia factor c deletion and DAZ copy number in azoospermia and severe oligozoospermia.
Azoospermia Factor C Subregion of the Y Chromosome.
Characterization of Deletions in the DYS385 Flanking Region and Null Alleles Associated with AZFc Microdeletions in Koreans.
Complex Y chromosome anomalies in an infertile male.
DAZ1/DAZ2 cluster deletion mediated by gr/gr recombination per se may not be sufficient for spermatogenesis impairment: a study of Chinese normozoospermic men.
Decreased fertilization rate and embryo quality after ICSI in oligozoospermic men with microdeletions in the azoospermia factor c region of the Y chromosome.
Detection of Partial Deletions of Y-chromosome AZFc in Infertile Men Using the Multiplex Ligation-dependent Probe Amplification Assay.
Development of a multiplex quantitative fluorescent PCR assay for identification of rearrangements in the AZFb and AZFc regions.
Diagnosis of the gr/gr Y chromosome microdeletion does not help in the treatment of infertile American men.
Differential effect of specific gr/gr deletion subtypes on spermatogenesis in the Chinese Han population.
Dynamic nature of the proximal AZFc region of the human Y chromosome: multiple independent deletion and duplication events revealed by microsatellite analysis.
Early detection of Y chromosome microdeletions in infertile men is helpful to guide clinical reproductive treatments in southwest of China.
Evolution of the DAZ gene and the AZFc region on primate Y chromosomes.
Gene copy number alterations in the azoospermia-associated AZFc region and their effect on spermatogenic impairment.
Gene copy number reduction in the azoospermia factor c (AZFc) region and its effect on total motile sperm count.
Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection.
GR/GR deletions within the azoospermia factor c region on the Y chromosome might not be associated with spermatogenic failure.
gr/gr-DAZ2-DAZ4-CDY1b deletion is a high-risk factor for male infertility in Tunisian population.
High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia.
Histology and sperm retrieval among men with Y chromosome microdeletions.
Identification and characterization of human VCY2-interacting protein: VCY2IP-1, a microtubule-associated protein-like protein.
Impact of Y chromosome AZFc subdeletion shows lower risk of fertility impairment in Siddi tribal men, Western Ghats, India.
Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions.
Microdeletions of a Y-specific marker, Yfm1, and implications for a role in spermatogenesis.
MicroRNA expression profiles in testicular biopsies of patients with impaired spermatogenesis.
Partial AZFc duplications not deletions are associated with male infertility in the Yi population of Yunnan Province, China.
Partial duplication at AZFc on the Y chromosome is a risk factor for impaired spermatogenesis in Han Chinese in Taiwan.
Poor intracytoplasmic sperm injection outcome in infertile males with azoospermia factor c microdeletions.
Prediction model for obtaining spermatozoa with testicular sperm extraction in men with non-obstructive azoospermia.
Prevalence of chromosomal abnormalities and Y chromosome microdeletion among men with severe semen abnormalities and its correlation with successful sperm retrieval.
Reproductive outcomes of intracytoplasmic sperm injection using testicular sperm and ejaculated sperm in patients with AZFc microdeletions: a systematic review and meta-analysis.
Sequence Read Depth Analysis of a Monophyletic Cluster of Y Chromosomes Characterized by Structural Rearrangements in the AZFc Region Resulting in DYS448 Deletion and DYF387S1 Duplication.
Specific expression of VCY2 in human male germ cells and its involvement in the pathogenesis of male infertility.
Sperm retrieval from a male with the rare 47, XXYqs variant of Klinefelter syndrome for intracytoplasmic sperm injection: A case report.
Sperm retrieval rate and reproductive outcome of infertile men with azoospermia factor c deletion.
Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection.
Study of AZFc partial deletion gr/gr in fertile and infertile Japanese males.
The Association of Partial Azoospermia Factor C Deletions and Male Infertility in Northwestern China.
The Low Prevalence of Y Chromosomal Microdeletions is Observed in the Oligozoospermic Men in the Area of Mato Grosso State and Amazonian Region of Brazilian Patients.
The reproductive outcome of an infertile man with AZFc microdeletions, via intracytoplasmic sperm injection in a high-risk pregnancy: Case report and literature review.
Useful marker for the estimation of a recombination pair in the partial azoospermia factor c (gr/gr) deletion using quantitative real-time polymerase chain reaction.
Y chromosome microdeletion and cytogenetic findings in male infertility: A cross-sectional descriptive study.
Y-chromosomal microdeletions and partial deletions of the Azoospermia Factor c (AZFc) region in normozoospermic, severe oligozoospermic and azoospermic men in Sri Lanka.
Y-chromosome haplogroup architecture confers susceptibility to azoospermia factor c microrearrangements: a retrospective study.
Y-chromosome haplogroups and susceptibility to azoospermia factor c microdeletion in an Italian population.
[Breakpoints located by sequence tagged sites of AZFc microdeletion in Chinese Han population].
[Sequence tagged sites of AZFc microdeletion in Chinese Han population].
Breast Neoplasms
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma.
Differential stimulation of VEGF-C production by adhesion/growth-regulatory galectins and plant lectins in human breast cancer cells.
Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor ? in women undergoing anesthesia and surgery for breast cancer.
Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis.
High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.
Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients.
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer.
Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.
Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.
The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
Ultrasound-mediated vascular endothelial growth factor C (VEGF-C) gene microbubble transfection inhibits growth of MCF-7 breast cancer cells.
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.
VWCE Functions as a Tumor Suppressor in Breast Cancer Cells.
[Expression of vascular endothelial growth factor C in human breast cancer cell lines MCF-7 and MCF-7/Adr]
[Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
[Role of short haipin RNA targeting vascular endothelial growth factor-C on biological characteristics of human breast cancer cell MCF-7]
[The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]
Bronchiolitis
Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis.
Carcinogenesis
Steroid receptor coactivator-1 interacts with NF-?B to increase VEGFC levels in human thyroid cancer.
[Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Carcinoma
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma.
Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells.
Expression and significance of vascular endothelial growth factor C from multiple specimen sources in esophageal squamous cell carcinoma.
Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.
Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma.
Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.
Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis.
Immunoexpression of VEGFR-3, but not the immunoexpression of VEGF-C or lymphatic density, is correlated with metastasis in lower lip squamous cell carcinoma.
Immunohistochemical expression of PDGFR, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment.
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Lymphatic dissemination of tumour cells and the formation of micrometastases.
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells.
Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck.
Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma.
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
prognostic significance of vascular endothelial growth factor C in systemic malignancies besides non-small cell lung carcinomas.
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.
The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma.
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature.
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms.
[Effect of interferon-gamma on the expression of vascular endothelial growth factor C on Hep-2 laryngeal carcinoma cell lines]
[Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
[Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance.]
[Expression of vascular endothelial growth factor C and survivin in gastric carcinoma and their clinical implications]
[Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma]
[Expression of VEGF and VEGF-C in laryngeal carcinoma and their clinical significance]
[Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma]
[Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma.]
[Interaction of vascular endothelial growth factor-C over-expression with tongue squamous cell carcinoma cell line Tca8113 with peri-carcinoma lymphatics]
[Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3]
Carcinoma, Hepatocellular
Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma.
Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma.
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
Role of VEGF-C Gene Polymorphisms in Susceptibility to Hepatocellular Carcinoma and Its Pathological Development.
Carcinoma, Non-Small-Cell Lung
Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
Decreased maspin combined with elevated vascular endothelial growth factor C is associated with poor prognosis in non-small cell lung cancer.
Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer.
Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung Cancer.
VEGF-C in non-small cell lung cancer: meta-analysis.
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
[Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer]
[Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance.]
[Expression of vascular endothelial growth factor C and its receptor VEGF-R3 and their significance in non-small cell lung cancer.]
[Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma.]
Carcinoma, Ovarian Epithelial
Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue.
Carcinoma, Renal Cell
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
Expression of 4E-BP1 and phospho-4E-BP1 correlates with the prognosis of patients with clear cell renal carcinoma.
Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis.
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Carcinoma, Squamous Cell
Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Immunoexpression of VEGFR-3, but not the immunoexpression of VEGF-C or lymphatic density, is correlated with metastasis in lower lip squamous cell carcinoma.
Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck.
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
[Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]
[Expression of VEGF-C and VEGFR-3 in human laryngeal squamous cell carcinomas and cervical metastatic lymph node tissues]
[Interaction of vascular endothelial growth factor-C over-expression with tongue squamous cell carcinoma cell line Tca8113 with peri-carcinoma lymphatics]
Cholangiocarcinoma
Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinoma.
Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages.
Colonic Neoplasms
Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer.
High-mobility group box 1 protein activating nuclear factor-?B to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis.
Colorectal Neoplasms
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
Vascular Endothelial Growth Factor C Disrupts the Endothelial Lymphatic Barrier to Promote Colorectal Cancer Invasion.
[The expression of vascular endothelial growth factor C, ETS-1, microvessal density, and microlymphaticdensity and their clinicopathologic in colorectal carcinoma]
Communicable Diseases
Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation.
Deafness
A novel frameshift variant of COCH supports the hypothesis that haploinsufficiency is not a cause of autosomal dominant nonsyndromic deafness 9.
Dengue
Spontaneous central vein thrombosis in a patient with activated protein C resistance and dengue infection: An association or causation?
Diabetic Retinopathy
Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.
Dry Eye Syndromes
Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
Endometriosis
Dysregulation of Vascular Endothelial Growth Factors and Their Neuropilin Receptors in the Eutopic Endometrium of Women With Endometriosis.
Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.
Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
Erythema
Non-invasive detection of local tissue responses to predict pressure ulcer development in mouse models.
Esophageal Neoplasms
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Expression of Stathmin and vascular endothelial growth factor C in esophageal cancer and their combined diagnostic value.
Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer.
Mucin 1 and Vascular Endothelial Growth Factor C Expression Correlates with Lymph Node Metastatic Recurrence in Patients with N0 Esophageal Cancer After Ivor-Lewis Esophagectomy.
Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients.
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
Esophageal Squamous Cell Carcinoma
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells.
Expression and significance of vascular endothelial growth factor C from multiple specimen sources in esophageal squamous cell carcinoma.
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Gastrointestinal Neoplasms
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial.
Glioblastoma
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.
Hearing Loss
Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.
[Mutation screening of the COCH gene in familial and sporadic patients with late onset nonsyndromic sensorineural hearing loss among Chinese population]
Hearing Loss, Sensorineural
A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.
Absence of COCH mutations in patients with Meniere disease.
Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
Massively Parallel Sequencing of a Chinese Family with DFNA9 Identified a Novel Missense Mutation in the LCCL Domain of COCH.
Hepatitis B
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer.
Hodgkin Disease
Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.
Hypertension
Circulating Lymphangiogenic Factors in Preeclampsia.
Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.
Involvement of the lymphatic system in salt-sensitive hypertension in humans.
Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.
Hypotension
Intradialytic hypotension: beyond hemodynamics.
Infections
Cleaved Cochlin Sequesters Pseudomonas aeruginosa and Activates Innate Immunity in the Inner Ear.
Evidence for the ancient origin of the NF-{kappa}B/I{kappa}B cascade: Its archaic role in pathogen infection and immunity.
Infertility
Detection of Partial Deletions of Y-chromosome AZFc in Infertile Men Using the Multiplex Ligation-dependent Probe Amplification Assay.
Infertility, Male
Study of AZFc partial deletion gr/gr in fertile and infertile Japanese males.
The Association of Partial Azoospermia Factor C Deletions and Male Infertility in Northwestern China.
Useful marker for the estimation of a recombination pair in the partial azoospermia factor c (gr/gr) deletion using quantitative real-time polymerase chain reaction.
[Study on the relationship between partial deletions in the azzospermia factor C region of Y chromosome and male infertility]
Inflammatory Bowel Diseases
Inflammation and Lymphatic Function.
Leiomyoma
Effect of anesthetic technique on serum vascular endothelial growth factor C and prostaglandin E2 levels in women undergoing surgery for uterine leiomyomas.
Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth.
Leukemia
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Leukemia, Myeloid, Acute
VEGFC antibody therapy drives differentiation of AML.
limulus clotting factor c deficiency
Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt.
Platelet-derived growth factor C deficiency in C57BL/6 mice leads to abnormal cerebral vascularization, loss of neuroependymal integrity, and ventricular abnormalities.
Liver Cirrhosis
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
Liver Neoplasms
Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China.
Lung Injury
A Novel Role of VEGFC in Cerebral Ischemia With Lung Injury.
Lung Neoplasms
Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression.
Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.
Decreased maspin combined with elevated vascular endothelial growth factor C is associated with poor prognosis in non-small cell lung cancer.
Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma.
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer.
Vascular Endothelial Growth Factor C as a Predictor of Early Recurrence and Poor Prognosis of Resected Stage I Non-small Cell Lung Cancer.
Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer.
Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer.
VEGF-C in non-small cell lung cancer: meta-analysis.
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
[Effects on lymphangiogenesis and angiogenesis of lung cancer with antisense oligonucleotides of vascular endothelial growth factor C]
[Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer]
[Expression of vascular endothelial growth factor C and its receptor VEGF-R3 and their significance in non-small cell lung cancer.]
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
Lymphatic Metastasis
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGF?R1/VEGF-D signaling.
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma.
Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma.
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.
Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma.
Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models.
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer.
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Steroid receptor coactivator-1 interacts with NF-?B to increase VEGFC levels in human thyroid cancer.
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (?35 Years).
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor.
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms.
VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer.
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
[Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma]
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
[Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]
[Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma]
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
[Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.]
[The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]
Lymphedema
A genetic Xenopus laevis tadpole model to study lymphangiogenesis.
Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema.
Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema.
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema.
Melanoma
Bartonella henselae Detected in Malignant Melanoma, a Preliminary Study.
Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.
Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
Meniere Disease
Absence of COCH mutations in patients with Meniere disease.
Mumps
Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection.
Mycosis Fungoides
Podoplanin Expression Correlates with Disease Progression in Mycosis Fungoides.
Nasopharyngeal Carcinoma
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
[Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma]
[Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma]
[Expression and relationship of EBV LMP1, COX-2 and VEGF-C in nasopharyngeal carcinoma]
Neoplasm Metastasis
Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice.
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.
Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor ? in women undergoing anesthesia and surgery for breast cancer.
Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer.
Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinoma.
Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma.
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.
Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Hedyotis diffusa Willd. inhibits VEGF?C?mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
High-mobility group box 1 protein activating nuclear factor-?B to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasis.
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
M2-Polarized Tumor-Associated Macrophage Infiltration of Regional Lymph Nodes Is Associated With Nodal Lymphangiogenesis and Occult Nodal Involvement in pN0 Pancreatic Cancer.
MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma.
Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread.
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer.
Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.
Vascular Endothelial Growth Factor C Disrupts the Endothelial Lymphatic Barrier to Promote Colorectal Cancer Invasion.
Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.
Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor.
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cellcarcinomas and its role in long-term survival after surgery.
Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer.
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
[Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma]
[Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
[Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis]
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
[Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.]
Neoplasm Micrometastasis
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Prognostic significance of VEGF-C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma.
[Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma]
Neoplasms
An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood.
Analyses of VEGFC/VEGF-D expressions, density and endothelial lymphatic proliferation in salivary gland neoplasms.
Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.
Anti-inflammatory effects of flap and lymph node transfer.
Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice.
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.
CCR7-expressing B16 melanoma cells downregulate interferon-?-mediated inflammation and increase lymphangiogenesis in the tumor microenvironment.
Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.
Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma.
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis.
Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Correlation of intratumoral lymphatic microvessel density, vascular endothelial growth factor C and cell proliferation in salivary gland tumors.
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model.
Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Hedyotis diffusa Willd. inhibits VEGF?C?mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.
Inhibition of angiogenesis by a novel neutralizing antibody targeting human VEGFR-3.
Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.
Intratumoral lymphangiogenesis and prognostic significance of VEGFC expression in gastric cancer.
Isolation and characterization of anti-neoplastic sturgeon factors.
Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models.
Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.
Lymphatic dissemination of tumour cells and the formation of micrometastases.
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells.
Metastasis associated protein 1 correlates with Hypoxia inducible-factor 1 alpha expression and lymphangiogenesis in esophageal cancer.
MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck.
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer.
Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
prognostic significance of vascular endothelial growth factor C in systemic malignancies besides non-small cell lung carcinomas.
Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
Prognostic significance of VEGF-C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma.
Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.
Role of VEGF-C Gene Polymorphisms in Susceptibility to Hepatocellular Carcinoma and Its Pathological Development.
Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA.
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE-2 cells.
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia.
The increased number of tumor-associated macrophage is associated with overexpression of VEGF-C, plays an important role in Kazakh ESCC invasion and metastasis.
The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy.
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Tracking tumor cells in lymphatics in a mice xenograft model by magnetic resonance imaging.
Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway.
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
URG11 promotes proliferation and induced apoptosis of LNCaP cells.
URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-?B signaling pathway.
Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.
Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells.
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.
Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms.
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
Vascular endothelial growth factor C-induced lymphangiogenesis decreases tumor interstitial fluid pressure and tumor.
Vascular endothelial growth factor-C expression as a biomarker of poor prognosis in esophageal squamous cell carcinoma: a meta-analysis.
Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.
Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
VEGF-C antisense oligoxydeonucleotide suppression of invasive ability of the A-549 lung carcinoma cell line.
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.
[Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]
[Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]
[Principles of the TNM system]
[Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]
[Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.]
[The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]
[VEGF-C and lymphatic vessels: a double-edged sword in tumor development and metastasis].
Neoplasms, Squamous Cell
VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.
Neuroblastoma
Anti-Müllerian hormone signaling is influenced by Follistatin 288, but not 14 other transforming growth factor beta superfamily regulators.
Neuroectodermal Tumors, Primitive
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Oligospermia
Analysis of partial azoospermia factor c deletion and DAZ copy number in azoospermia and severe oligozoospermia.
AZFc deletions do not affect the function of human spermatogonia in vitro.
MicroRNA expression profiles in testicular biopsies of patients with impaired spermatogenesis.
Orchitis
Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection.
Osteoarthritis
Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis.
Ovarian Neoplasms
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Pancreatic Neoplasms
Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer.
Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer.
Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro.
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]
Periodontal Diseases
Lymphangiogenesis is induced during development of periodontal disease.
Periodontitis
Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss.
Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation.
Peritonitis
Immunohistochemical staining for endotoxin using horseshoe crab factor C in fecal peritonitis.
Polycystic Kidney Diseases
Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases.
Pre-Eclampsia
Allelic variations in angiogenic pathway genes are associated with preeclampsia.
CYR61 modulates the vascular endothelial growth factor c expression of decidual NK cells via PI3K/AKT pathway.
Pressure Ulcer
Non-invasive detection of local tissue responses to predict pressure ulcer development in mouse models.
Prediction of healing in Category I pressure ulcers by skin blotting with plasminogen activator inhibitor 1, interleukin-1?, vascular endothelial growth factor C, and heat shock protein 90?: A pilot study.
Prostatic Hyperplasia
Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasia.
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
Prostatic Neoplasms
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasia.
Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
URG11 promotes proliferation and induced apoptosis of LNCaP cells.
Protein S Deficiency
Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt.
Pseudomonas Infections
Cleaved Cochlin Sequesters Pseudomonas aeruginosa and Activates Innate Immunity in the Inner Ear.
Pterygium
Expression of vascular endothelial growth factor C in human pterygium.
Rectal Neoplasms
Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
[Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Renal Insufficiency, Chronic
Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects.
Salivary Gland Neoplasms
Analyses of VEGFC/VEGF-D expressions, density and endothelial lymphatic proliferation in salivary gland neoplasms.
Scabies
The possible role of factor C in common scab disease development.
Sepsis
The Diagnostic and Prognostic Role of Vascular Endothelial Growth Factor C in Sepsis and Septic Shock.
Sertoli Cell-Only Syndrome
MicroRNA expression profiles in testicular biopsies of patients with impaired spermatogenesis.
Shock, Septic
Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications.
The Diagnostic and Prognostic Role of Vascular Endothelial Growth Factor C in Sepsis and Septic Shock.
Small Cell Lung Carcinoma
[Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer]
Squamous Cell Carcinoma of Head and Neck
Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells.
[Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma]
[Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma]
[Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3]
Stomach Neoplasms
Combined targeting of vascular endothelial growth factor C (VEGFC) and P65 using miR-27b-3p agomir and lipoteichoic acid in the treatment of gastric cancer.
Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients.
MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.
Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
[Effects of quercetin on the expression of VEGF-C and VEGFR-3 in human cancer MGC-803 cells.]
[Experimental research of the inhibition of vascular endothelial growth factor C expression in gastric cancer by targeting RNA interference]
Stroke
Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial.
Synovitis
VEGF-C Gene Polymorphisms Increase Susceptibility to Rheumatoid Arthritis.
Thrombophilia
Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.
Thrombosis
The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies.
Thyroid Cancer, Papillary
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
[Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma]
Tongue Neoplasms
Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer.
Triple Negative Breast Neoplasms
Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells.
Tuberculosis
A Role for Mycobacterium tuberculosis Sigma Factor C in Copper Nutritional Immunity.
Tuberous Sclerosis
Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy.
Urinary Bladder Neoplasms
circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGF?R1/VEGF-D signaling.
Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer.
MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells.
VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Uterine Cervical Neoplasms
Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.
Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression.
Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas.
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B.
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.
Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer.
Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
Virus Diseases
Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive.